Symbol="ENTX"
AssetType="Common Stock"
Name="Entera Bio Ltd"
Description="Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally administered large molecule therapies for unmet medical needs. The company is headquartered in Jerusalem, Israel."
CIK="1638097"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="21898600"
EBITDA="-11789000"
PERatio="None"
PEGRatio="None"
BookValue="0.35"
DividendPerShare="0"
DividendYield="0"
EPS="-0.39"
RevenuePerShareTTM="0.002"
ProfitMargin="0"
OperatingMarginTTM="-179.56"
ReturnOnAssetsTTM="-0.437"
ReturnOnEquityTTM="-0.77"
RevenueTTM="66000"
GrossProfitTTM="33000"
DilutedEPSTTM="-0.39"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.915"
AnalystTargetPrice="6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="63.37"
PriceToBookRatio="1.262"
EVToRevenue="13.56"
EVToEBITDA="-0.277"
Beta="1.834"
num_52WeekHigh="1.95"
num_52WeekLow="0.472"
num_50DayMovingAverage="0.826"
num_200DayMovingAverage="0.849"
SharesOutstanding="28814000"
DividendDate="None"
ExDividendDate="None"
symbol="ENTX"
open="0.76"
high="0.81"
low="0.76"
price="0.80"
volume="28160.00"
latest_trading_day="2023-08-04"
previous_close="0.76"
change="0.04"
change_percent="5.2632%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="59"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="41"
Volume_recent_avg="45684"
Change_recent_avg="-0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.84"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="41"
Aroon_momentum_negative="59"
image_negative_thumbnail_id_1="507"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0098.jpeg"
image_negative_thumbnail_id_2="173"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0003.jpeg"
image_neutral_thumbnail_id_1="576"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="1000"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0162.jpeg"
image_positive_thumbnail_id_2="951"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0113.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
